Main > HEMATOLOGY > FR. S. CAD>Treat.>SutimliMAb-Jome>



FR. S. CAD>Treat.>SutimliMAb-Jome>'s subsections
(*) USA Approval Date: 2022. 02.04
>Injection for IV Use
Company
RTM
RTM Web-Site
USA Patent Numbers

FR. S. CAD>Treat.>SutimliMAb-Jome>'s products
This section has no products